In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under ...

The Supreme Court will soon hear oral arguments for a case that threatens coverage of preventive services without ...

Healthcare systems are grappling with immense social and economic pressures, including increasing worker burnout rates, an aging population requiring more attentive care, and severe staffing ...

According to the nonpartisan Congressional Budget office (CBO), 93% of non-Medicare spending goes to Medicaid and the Children’s Health Insurance Program (CHIP). During the next 10 years, these ...

Pfizer is playing catch-up in the crowded field of obesity medicines, but it hoped to compete with a daily pill alternative to currently available injectable GLP-1 products. Instead, Pfizer is ...

As we navigate through 2025, the American healthcare system stands at a critical juncture. The demographic shifts that have been gradually unfolding are now accelerating, creating challenges that ...

What if type 2 diabetes could nearly be eliminated? This isn’t even a thought experiment; it’s increasingly becoming a reality. A recent study found that Tirzepatide lowered the risk of ...